Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
Conditions: Malignant Pleural Mesotheliomas (Mpm); Malignant Pleural Effusions (Mpe); Epithelial Tumors, Malignant; Pleural Effusions, Malignant; Mesothelin (Msln) Interventions: Procedure: Cytoreductive surgery; Drug: LMB-100; Diagnostic Test: Immunohistochemical Assay for Mesothelin Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials